Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Aug;16(4):389-396.
doi: 10.1007/s12687-024-00732-9. Epub 2024 Sep 26.

Building a National Policy for Rare Disease in Brazil

Affiliations
Review

Building a National Policy for Rare Disease in Brazil

Têmis Maria Félix et al. J Community Genet. 2025 Aug.

Abstract

Rare diseases (RD) are individually rare, although encompass a significant proportion of the population, affecting not only the individuals but also their families. In Brazil RD is defined by the Ministry of Health as a disorder that affects up to 65 individuals in 100,000, or 1.3 individuals in every 2,000. In this review the environment that led to the publication of a National Policy for Comprehensive Care for People of Rare Disease in 2014, a national plan with the aim to decrease morbidity and mortality of RD, improving the care of people with RD in the public health system are described. The process that finally led to such policy took over a decade, moving forward not only due to technical needs, but having patient organizations as essential actors and advocates. Specialized centers in RD were licensed and, since its publication, 33 centers have been accredited; such process, however, has been slow and concentrated in specific regions and larger cities of the country. Despite the incorporation of genetic tests in 2014 and exome sequencing later in 2020, many genetic tests are not offered by specialized centers, with unequal availability across the country. Public health system in Brazil uses ICD-10 for disease coding, preventing appropriate epidemiologic knowledge of RD in Brazil. Incorporation of new technologies as orphan drugs has been in place and regulation for expedite licensing for new RD drugs were issued, although high cost and availability to RD population has been a challenge.

Keywords: Brazil; Public health; Public policy; Rare diseases.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Timeline of the National Policy for Rare Diseases in Brazil
Fig. 2
Fig. 2
Distribution of Rare Disease Reference Services (black) and Specialized Care Services for RD (red/*) across the five regions of Brazil
Fig. 3
Fig. 3
Number of procedures performed per year, categorized by different clinical diagnostic procedures and genetic counseling. Data collected on July 5th, 2024 from Datasus Tabnet Win32 3.2

Similar articles

Cited by

References

    1. Arnold RJ, Bighash L, A Bryón Nieto, G Tannus Branco de Araújo, Gay-Molina JG, F Augustovski (2015) The role of globalization in drug development and access to orphan drugs: orphan drug legislation in the US/EU and in Latin America. F1000Research 4:57. 10.12688/f1000research.4268.1 - PMC - PubMed
    1. Aymé S, Bellet B, Rath A (2015) Rare diseases in ICD11: making rare diseases visible in health information systems through appropriate coding. Orphanet J Rare Dis 10:35. 10.1186/s13023-015-0251-8 - PMC - PubMed
    1. Biglia LV, Mendes JS, Lima MT, Aguiar PM (2021) Incorporation of drugs for rare diseases in Brazil: is it possible to have full access to these patients? Ciênc saúde Coletiva 26(11). 10.1590/1413-812320212611.26722020 - PubMed
    1. Brasil (1990) Lei 8080 de 19 de Setembro De 1990. Dispõe sobre as condições para a promoção, proteção e recuperação da saúde, a organização e o funcionamento dos serviços correspondentes e dá outras providências. Diário Oficial da União
    1. Brasil (2001a) Ministério da Saúde. Portaria N.º 470/GM, De 6 de Abril De 2001 – Institui a comissão sobre acesso e uso do genoma humano. Diário Oficial da União

LinkOut - more resources